Stocks · Health care · Pharmaceutical Preparations

Amneal Pharmaceuticals, Inc.

AMRX Clue Score38

Fiscal year ends December CIK 0001723128 Results filed 3 Nov 2026

Add to watchlist

What the insiders did Net selling

By person

16 insiders · 8 transactions

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Nikita Shah

Executive Vice President

—

$4.14M (2)

−$4.14M

253,390

0.0793%

$4.47M

−13.1%

Jason B. Daly

EVP, Chief Legal Officer

—

$3.77M (2)

−$3.77M

35,171

0.0110%

$620.42K

−38.6%

John Kiely

Director

—

$882.00K (1)

−$882.00K

200,252

0.0627%

$3.53M

−21.7%

Ted C Nark

Director

—

$586.00K (1)

−$586.00K

325,848

0.1020%

$5.75M

+8.3%

Deborah M. Autor

Director

—

$450.56K (1)

−$450.56K

93,660

0.0293%

$1.65M

+0.3%

Tushar Bhikhubhai Patel

10% owner

—

—

—

61,341,678

19.21%

$1.08B

+14.5%

Chirag K. Patel

President & Co-CEO

—

—

—

7,775,204

2.43%

$137.15M

+1,417%

Chintu Patel

Co-CEO

—

—

—

7,770,255

2.43%

$137.07M

+1,416%

Gautam Patel

Director

—

—

—

1,927,595

0.6036%

$34.00M

−5.9%

Paul M Meister

Director

—

—

—

832,800

0.2608%

$14.69M

+14.4%

Tasos Konidaris

Executive Vice President & CFO

—

—

—

449,434

0.1407%

$7.93M

−14.8%

Jeffrey P. George

Director

—

—

—

344,614

0.1079%

$6.08M

+27.9%

Shlomo Yanai

Director

—

—

—

320,804

0.1005%

$5.66M

+30.6%

J Kevin Buchi

Director

—

—

—

282,520

0.0885%

$4.98M

−55.7%

Emily Peterson Alva

Director

—

—

—

211,029

0.0661%

$3.72M

−15.8%

Andrew S Boyer

Executive Vice President

—

—

—

193,646

0.0606%

$3.42M

−24.6%